Allspring Global Investments’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-100
| Closed | -$104 | – | 1891 |
|
|
2024
Q3 | $104 | Buy |
+100
| New | +$104 | ﹤0.01% | 2425 |
|
|
2024
Q2 | – | Sell |
-10,446
| Closed | -$25K | – | 2402 |
|
|
2024
Q1 | $25K | Buy |
10,446
+2,201
| +27% | +$5.26K | ﹤0.01% | 2063 |
|
|
2023
Q4 | $27.5K | Sell |
8,245
-31,764
| -79% | -$106K | ﹤0.01% | 1933 |
|
|
2023
Q3 | $150K | Sell |
40,009
-2,279
| -5% | -$8.52K | ﹤0.01% | 1840 |
|
|
2023
Q2 | $181K | Buy |
42,288
+4,237
| +11% | +$18.1K | ﹤0.01% | 1844 |
|
|
2023
Q1 | $260K | Sell |
38,051
-2,596
| -6% | -$17.8K | ﹤0.01% | 1747 |
|
|
2022
Q4 | $322K | Buy |
40,647
+5,496
| +16% | +$43.5K | ﹤0.01% | 1707 |
|
|
2022
Q3 | $337K | Buy |
35,151
+5,632
| +19% | +$54K | ﹤0.01% | 1670 |
|
|
2022
Q2 | $213K | Sell |
29,519
-25,279
| -46% | -$182K | ﹤0.01% | 1800 |
|
|
2022
Q1 | $707K | Buy |
54,798
+1,094
| +2% | +$14.1K | ﹤0.01% | 2064 |
|
|
2021
Q4 | $857K | Buy |
+53,704
| New | +$857K | ﹤0.01% | 2032 |
|